Clinical trial

Association of Obesity and Cardiovascular Outcomes in Patients With Atrial Fibrillation : a Korean Nationwide Cohort Study

Name

AJOUIRB-EXP-2021-398

Description

In this study, the investigators evaluated the association between various measures of adiposity \[BMI and waist circumference (WC)\] and clinical outcomes in Asian patients with AF who were prescribed OAC, using a nationwide population based cohort.

Trial arms

Trial start

2022-01-01

Estimated PCD

2024-10-31

Trial end

2024-12-31

Status

Active (not recruiting)

Treatment

Oral anticoagulant

Oral anticoagulant that was continued at least 25days, inculding warfarin and new oral anticoagulant (NOAC)

Arms:

Atrial fibrillation with oral anticoagulant

Other names:

Oral anticoagulant medication

Size

56272

Primary endpoint

Composite of Outcomes

5 years

Eligibility criteria

Inclusion Criteria: * Oral anticoagulant (OAC) new users diagnosed with atrial fibrillation (AF) between January 2015 and December 2020 Exclusion Criteria: * Patients aged \<20 years * Valvular AF patients * Possible alternative indications for OAC (pulmonary embolism, deep vein thrombosis, or recent joint replacement surgery) * Cancer patients

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '5 Years', 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'OTHER'}, 'enrollmentInfo': {'count': 56272, 'type': 'ACTUAL'}}

Updated at

2023-07-27

1 organization

1 product

4 indications

Organization

Ajou University School of Medicine

Product

Indication

Indication

Indication

Indication